“…The recent elucidation of the genome of Tupaia belangeri chinensis confirmed the close genomic relationship between Tupaia belangeri and primates ( Fan et al, 2013 ). As a favorable animal model, the tree shrew has been used for many human disease studies, including research on depression ( Fuchs, 2005 ; Wang et al, 2011 ; 2012 ; 2013 ), drug addiction ( Sun et al, 2012 ; Zhang et al, 2011 ), virus infection ( Amako et al, 2010 ; Yan et al, 1996 ; Yang et al, 2005 ), bacterial infection ( Li et al, 2012 ), breast cancer ( Elliot et al, 1966 ; Ge et al, 2016 ; He et al, 2016 ; Xia et al, 2012 ), glioblastoma ( Tong et al, 2017 ), thrombosis ( Endo et al, 1997 ), metabolic diseases ( Wu et al, 2013 ; 2016 ; Zhang et al, 2015 ; 2016 ), stem spermatogonium transgenics ( Li et al, 2017 ), and myopia ( Norton et al, 2006 ). Recently, pharmacological research through drug target prediction and genomic and transcriptomic scale analysis has shown that more than half of the drug target proteins identified from the tree shrew genome demonstrate higher similarity to human targets than that of the mouse, as validated by the constitutive expression of proteinase-activated receptors ( Zhao et al, 2014 ).…”